Apollon Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
+583
New +$216K 0.03% 281
2026
Q1
Sell
-626
Closed -$220K 266
2025
Q4
$220K Buy
+626
New +$212K 0.03% 245
2025
Q3
Sell
-591
Closed -$230K 225
2025
Q2
$230K Buy
591
+1
+0.2% +$402 0.05% 196
2025
Q1
$257K Buy
590
+13
+2% +$5.22K 0.06% 179
2024
Q4
$213K Sell
577
-6
-1% -$2.51K 0.05% 179
2024
Q3
$303K Buy
583
+38
+7% +$20.3K 0.09% 134
2024
Q2
$295K Hold
545
0.1% 120
2024
Q1
$283K Hold
545
0.1% 126
2023
Q4
$257K Buy
+545
New +$252K 0.1% 123

Other funds holding ELV

Apollon Financial's ELV Position: Q2 2026 in Review

Apollon Financial opened a new position in Elevance Health (ELV) in Q2 2026: 583 shares worth $226K. The stake represents 0.03% of the portfolio and ranks #281 among its holdings. This is a return to the name: Apollon Financial previously reported a position in ELV as recently as Q4 2025.

Apollon Financial first reported a position in ELV in Q4 2023 and has held it in 9 quarters since. The position peaked at $303K in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Apollon Financial held 583 shares of Elevance Health worth $226K as of Q2 2026.
  • Elevance Health was a new Apollon Financial position in Q2 2026.
  • Elevance Health made up 0.03% of Apollon Financial's portfolio in Q2 2026, its #281 holding.
  • Apollon Financial first reported a position in Elevance Health in Q4 2023 and has held it in 9 quarters since.
  • Apollon Financial's Elevance Health position peaked at $303K in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Apollon Financial's 13F filing for Q2 2026, filed 23 Jul 2026.